Loading...

Loading...

UNAM Breast Cancer Vaccines Move Toward Human Trials
By MBN Staff - Wed, 12/31/2025 - 12:16
UNAM researchers developed therapeutic breast cancer vaccines with preclinical success, clearing the path for future human trials.
https://mexicobusiness.news/tag/precision-medicine
More Health
Before the Stroke: From Genetic Risk to Preventive Solutions
By Gustavo Rodríguez Leal - Mon, 09/29/2025 - 07:30
Genetic testing for CVDs helps with early detection and personalized prevention to reduce risk and mortality, writes Gustavo Rodríguez.
Personalized Medicine: Harnessing Genetics for Improved Care
By Aura Moreno - Wed, 09/10/2025 - 14:12
Mexico embraces precision medicine and integrating genomics to improve outcomes, prevention, and healthcare efficiency.
Personalized Medicine: A Potential Ally of Mexico’s Health System
By Sofía Garduño - Tue, 08/26/2025 - 13:12
Mexico explores personalized medicine to improve care, cut costs, and position itself as a regional leader in genomics.

Ethical Genomics: The Key to Sustainable Innovation
By Jorge Melendez Zajgla - Mon, 08/25/2025 - 07:00
There is a critical need for ethical planning in genomics, emphasizing data privacy, regulation, and access. Jorge Melendez Zajgla explains.
Pembrolizumab Shows 90% Success in Rare Melanoma Trial
By Aura Moreno - Mon, 08/18/2025 - 16:57
A UCLA trial finds pembrolizumab shrinks or eliminates tumors in 90% of desmoplastic melanoma patients.
HopeAI Joins Mayo Clinic Platform to Advance Drug Development
By MBN Staff - Mon, 08/18/2025 - 10:15
HopeAI joins Mayo Clinic Platform to accelerate drug development, using AI and real-world data for faster, more reliable clinical trials.
The Silent AI Revolution Changing How We Heal
By Sandra Sánchez-Oldenhage - Wed, 08/06/2025 - 06:30
AI is revolutionizing healthcare in Mexico, personalizing medicine, and transforming clinical research, writes Sandra Sánchez-Oldenhage.
Donanemab Gains EMA Panel Support for Alzheimer’s Treatment
By MBN Staff - Mon, 07/28/2025 - 08:59
Donanemab receives EMA panel’s recommendation for treating early Alzheimer’s, with implications for healthcare systems across the world.
Novo Nordisk, Fangzhou Partner to Tackle Chronic Diseases
By MBN Staff - Fri, 07/18/2025 - 10:26
Fangzhou and Novo Nordisk partner to deliver digital tools for chronic disease management, focusing on diabetes and obesity.